翻訳と辞書 |
Satavaptan
Satavaptan (INN; codenamed SR121463, planned tradename Aquilda) is a vasopressin-2 receptor antagonist undergoing research for the treatment of hyponatremia. It is also being studied for the treatment of ascites. It was developed by Sanofi-Aventis. As of 2008, it is under regulatory review in the European Union. ==References==
抄文引用元・出典: フリー百科事典『 ウィキペディア(Wikipedia)』 ■ウィキペディアで「Satavaptan」の詳細全文を読む
スポンサード リンク
翻訳と辞書 : 翻訳のためのインターネットリソース |
Copyright(C) kotoba.ne.jp 1997-2016. All Rights Reserved.
|
|